1.Study on the bioavailability of amoxicilline in the form of granules for syrup
Pharmaceutical Journal 2000;269(12):21-23
The bioavailability of amoxicilline for oral suspension was studied. The plasma concentrations of amoxicilline were measured by high pressure liquid chromatography (HPLC) using UV detector. The results of this study indicate that peak concentration (Cmax) of amoxicillin for oral suspension is 35.8 mcg/ml, time of peak concentration (tmax) is 1h and relative bioavailability is 137% and 169.5% comparing with capsules of Hamburg, pharmaceutical factory B, respectively.
Amoxicillin
;
Pharmaceutical Preparations
2.Study on the bioavailability of amoxicilline in the form of granules for syrup
Pharmaceutical Journal 1999;282(10):14-15
The bioavailability of amoxiciline for oral suspension was determined using urinary excretion method. The average cumulative (mg) amoxiciline excreted after 24 hour for capsule (Hamburg), capsule (pharm.fac.B) and granule for suspension is 405.3mg, 341.2mg and 519.9mg, respectively.
Amoxicillin
;
Pharmaceutical Preparations
3.Investigation on bioavailability and biogical equivalence of 3 amoxicilline products
Pharmaceutical Journal 2004;44(12):21-24
The study was carried out on 18 healthy volunteers (9 men and 9 women), from 21 - 36 years old, all of them don’t be alcohol and smoke addiction. The result: in the experience condition, the plasma concentration of amoxcilin while using 1000mg tablet, 2 times/24 hours is higher than dose 500mg, 3 times/24 hours for both tablet and capsule. The treatment regimen based on 500mg tablet, 3 times/24 hours ensures more rapid absorption than on 500mg capsule, but it don’t change the bioavailable and the bioequivalence of drug
Biological Availability
;
Amoxicillin
;
Therapeutics
4.Acute Exacerbation of Myasthenia Gravis after Amoxicillin Therapy
Journal of the Korean Neurological Association 2019;37(2):201-202
No abstract available.
Amoxicillin
;
Myasthenia Gravis
5.Comparison between UV and HPLC methods in the dosage of pharmaceutical products containing a mixture of 2 components amoxicillin and clavulanic acid
Pharmaceutical Journal 2003;0(6):29-32
UV - spectrophotometric (UV) and high performance liquid chromatographic methods (HPLC) were described in determining amoxicillin and clavulanic acid in pharmaceutical preparations. Spectrophotometrically, amoxicillin was determined by measuring the absorbance values at 320 nm in buffer-CuS04 solution (pH 5.2) for amoxicillin and at 313 nm in imidazol solution (pH 6.8) for clavulanic acid. Beer's Law was obeyed in range 12 - 32mg. ml-1 for amoxicillin and 12 - 22 mg. ml-1 for clavulanic acid. The simultaneous HPLC method depended upon using a reserved phase RP18 column at ambient temperature with a mobile phase consisting of methanol - phosphate solution pH 4.4 (4:96) at a flow rate 1ml.min-1. Quantitation was achieved by UV detection at 220 nm. Calibration curve was linear over the concentration range 50-150 mg. ml-1 for amoxicillin and 15-35 mg. ml-1 for clavulanic acid. Both spectrophotometry and HPLC method showed good linear correlation, precision and accuracy. The obtained results from spectrophotometry and HPLC method showed no significant difference. Both methods were successfully applied to the assay of commercial tablets. The procedures were rapid, simple and suitable for quality control applications
Pharmaceutical Preparations
;
Amoxicillin
;
Clavulanic Acid
6.Evaluation of Four Methods for Antimicrobial Susceptibility Testing of Helicobacter pylori in Routine Practice.
Jung Oak KANG ; Dongsoo HAN ; Tae Yeal CHOI
Korean Journal of Clinical Microbiology 2005;8(1):82-89
BACKGROUND: We compared currently available four antimicrobial susceptibility test methods for H.pylori to find out a practical method suitable for testing a few strains of H.pylori at a time in the clinical microbiology laboratory. METHODS: With 37 clinical isolates of H.pylori, antimicrobial susceptibility tests were performed against amoxicillin (AMX), clarithromycin (CLR), and metronidazole (MTZ) using disk diffusion method with egg yolk emulsion (EYE) media, E test with EYE and Mueller Hinton blood agar plate (MH BAP), and modified broth microdilution methods (mBMD). RESULTS: The results of AMX and CLR showed a complete agreement between the four methods. For MTZ, however, a significant discrepancy was observed between the results obtained by the four methods. In four strains exhibiting high minimal inhibitory concentrations (MIC, > or =32 mg/L) to MTZ, category agreement was excellent, but correlation was not good in 13 strains with the MTZ MICs of 8 to 16 mg/L. In 20 strains with MTZ MICs between 0.25 mg/L and 4 mg/L, category agreement was excellent, but correlation between MICs or inhibitory zone diameters was not good. Etest EYE and Etest MH BAP methods showed a 100% agreement in the susceptibility category of MTZ. CONCLUSION: In routine practice, the most practical method for testing susceptibility of H.pylori to AMX and CLR seems to be the disk diffusion method with EYE or MH BAP. But for MTZ, a duplicate test using both Etest and disk diffusion test is recommended until more standardized, economical, and technically easier test methods become available.
Agar
;
Amoxicillin
;
Clarithromycin
;
Diffusion
;
Egg Yolk
;
Helicobacter pylori*
;
Helicobacter*
;
Metronidazole
7.Expression of p53 Protein in Squamous Cell Carcinomas of Human Skin.
Eui Soo PARK ; Joon Young SONG
Korean Journal of Dermatology 1994;32(6):955-961
BACKGROUND: Mutations in the p53 gene are the most frecjuent genetic alterations found in human cancers to date. Bvidense suggests that wild-type p53 is a tumor suppressor protein, crucial for the negative regulative of cell cycling, and requiring loss of function mutations for tumorigenesis. OBJECTIVE: Our purposr is to investigate the expression pattern of the p53 protein in the squamous cell carcinomas(SCCs) of the human skin. METHODS: We studied p53 protein expression, using DO7 mnoclonal antibody immunohi-stochemistry, in 29 SCCs of the skin. Also, we compared the p53 expression depending upon with or without a history of UV exposure. RESULTS: p53 immunoreactivity was observed in 48% (14 of 29) of SCCs and was not seen in normal skin. In 56% (16/29) SCCs the tumors were developed on UV-light exposure area. SCCs were divided on histopatal biological criteria in to three categories, well, moderately, or poorly differentiated. Although no significant differenie in the prevalence of p53 immunoreactivity was obierved between these groups, positive, strong staining was observed more frequently in poorly differentiated than in well-differe: treated tumors. CONCLUSION: Accumulat,i,on of p53 protein, suggestive in nessary cases of p53 gene mutation and hence loss of tumors upperesor function, may play a role in the tumorigenesis of SCCs.
Amoxicillin
;
Carcinogenesis
;
Carcinoma, Squamous Cell*
;
Genes, p53
;
Humans*
;
Prevalence
;
Skin*
8.A comparison of the efficacy of amoxicillin and nasal irrigation in treatment of acute sinusitis in children.
Abolfazl KHOSHDEL ; Gholam Reza PANAHANDE ; Mohamad Kazem NOORBAKHSH ; Mohamad Reza MALEK AHMADI ; Masoud LOTFIZADEH ; Neda PARVIN
Korean Journal of Pediatrics 2014;57(11):479-483
PURPOSE: The efficacy of antibiotic therapy for acute sinusitis is controversial. This study aimed to compare the efficacies of amoxicillin with nasal irrigation and nasal irrigation alone for acute sinusitis in children. METHODS: This randomized, double-blind, controlled study included 80 children aged 4-15 years with a clinical presentation of acute sinusitis. Patients were randomly assigned to receive either amoxicillin (80 mg/kg/day) in 3 divided doses orally for 14 days with saline nasal irrigation (for 5 days) and 0.25% phenylephrine (for 2 days) or the same treatment without amoxicillin. Clinical improvements in their initial symptoms were assessed on days 3, 14, 21, and 28. RESULTS: On day 3, patients in the amoxicillin with nasal irrigation group showed significant clinical improvement (P=0.001), but there was no significant difference in the degree of improvement between the amoxicillin with nasal irrigation and nasal irrigation alone groups during follow-up (P>0.05). In addition, no significant differences were seen in age, sex, and degree of improvement between groups (P>0.05). CONCLUSION: High-dose amoxicillin with saline nasal irrigation relieved acute sinusitis symptoms faster and more often than saline nasal irrigation alone. However, antibiotic treatment for acute sinusitis confers only a small therapeutic benefit over nasal irrigation.
Amoxicillin*
;
Child*
;
Follow-Up Studies
;
Humans
;
Nasal Lavage*
;
Phenylephrine
;
Sinusitis*
9.Study on dosage of amoxicilline and clavulanic acid in human serum by HPLC method
Pharmaceutical Journal 2005;353(9):23-26
A simple, rapid, sensitive, precise and accurate high-performance liquid chromatographic (HPLC) method with ultraviolet detection at wavelength of 205nm has been validated for the simultaneous determination of amoxicillin and clavulanic acid in human serum. Serum samples were deproteinized with methanol. The separation of 2 obtained compounds was achieved using a reversed phase C8 column and a mobile phase, consisting of acetonitrile-phosphate solution. The calibration curves were linear over the concentration range of 0.625 – 10 g.ml-1 for amoxicillin and 0.3125 – 5 g.ml-1 for clavulanic acid. The quantitative limits are 0.625 and 0.3125 g.ml-1 for amoxicillin and clavulanic acid. Analytical recoveries from human serum ranged from 93 to 96% for both components. This method was fully validated. It allows the simultaneous assay of amoxicillin and clavulanic acid in biomedical applications. This method has been successfully applied to a pilot pharmacokinetic study in 3 healthy volunteers after a single oral administration of amoxicillin and clavulanic acid combination
Amoxicillin
;
Clavulanic Acid
;
Serum
;
Chromatography, High Pressure Liquid
10.Study on the relationship between HP killing level and age, morbidity duration and HP contaminated level in treating HP contaminated chronic gastritis of amoxicilline combined with sucrategel regimen
Journal of Practical Medicine 2004;471(1):32-34
Study 33 chronic gastritis Helicobacter pylori infected Amoxicillin 500 mg tablet, 1 tablet x 2 times daily during 10 first days and sucrategel 1g packet x 2 times daily in 30 days. Results did not relation between bactericide with the age and the duration of disease. Thee less HP infected before the treatment, the more bactericide capacity after treatment and visversa.
Helicobacter pylori
;
Morbidity
;
Age factors
;
Therapeutics
;
Gastritis
;
Amoxicillin